Compounds > 18-hydroxy-19-norcorticosterone
Page last updated: 2024-09-03

18-hydroxy-19-norcorticosterone and vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine-

18-hydroxy-19-norcorticosterone has been researched along with vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine- in 1 studies

Compound Research Comparison

Studies
(18-hydroxy-19-norcorticosterone)		Trials
(18-hydroxy-19-norcorticosterone)		Recent Studies (post-2010)
(18-hydroxy-19-norcorticosterone)		Studies
(vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine-)		Trials
(vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine-)		Recent Studies (post-2010) (vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine-)
900357522

Protein Interaction Comparison

ProteinTaxonomy18-hydroxy-19-norcorticosterone (IC50)vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine- (IC50)
Vasopressin V1a receptorHomo sapiens (human)0.0011

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujishima, M; Takata, Y; Takishita, S; Yamashita, Y1

Other Studies

1 other study(ies) available for 18-hydroxy-19-norcorticosterone and vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine-

ArticleYear
Lack of increase in sodium concentration of cerebrospinal fluid in DOCA-salt hypertensive rats.
    American journal of hypertension, 1988, Volume: 1, Issue:3 Pt 3

    Topics: 18-Hydroxycorticosterone; Adrenalectomy; Aldosterone; Animals; Arginine Vasopressin; Blood Pressure; Corticosterone; Hypertension; Rats; Rats, Inbred SHR

1988